UBS Group’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $189M | Buy |
1,980,435
+1,066,071
| +117% | +$102M | 0.02% | 698 |
|
|
2026
Q1 | $94.8M | Buy |
914,364
+63,550
| +7% | +$7.2M | 0.01% | 1098 |
|
|
2025
Q4 | $85.8M | Sell |
850,814
-506,574
| -37% | -$55M | 0.01% | 1136 |
|
|
2025
Q3 | $167M | Sell |
1,357,388
-441,903
| -25% | -$54.8M | 0.03% | 686 |
|
|
2025
Q2 | $216M | Buy |
1,799,291
+489,309
| +37% | +$65.3M | 0.04% | 508 |
|
|
2025
Q1 | $193M | Buy |
1,309,982
+336,575
| +35% | +$51.4M | 0.04% | 518 |
|
|
2024
Q4 | $158M | Buy |
973,407
+411,824
| +73% | +$67.4M | 0.03% | 632 |
|
|
2024
Q3 | $91.5M | Sell |
561,583
-108,831
| -16% | -$16.1M | 0.02% | 772 |
|
|
2024
Q2 | $91.5M | Buy |
670,414
+174,293
| +35% | +$24.2M | 0.02% | 689 |
|
|
2024
Q1 | $76M | Buy |
496,121
+134,904
| +37% | +$20.1M | 0.02% | 793 |
|
|
2023
Q4 | $51.5M | Sell |
361,217
-91,851
| -20% | -$12.2M | 0.02% | 958 |
|
|
2023
Q3 | $59.4M | Sell |
453,068
-165,436
| -27% | -$25.1M | 0.02% | 741 |
|
|
2023
Q2 | $98.4M | Buy |
618,504
+82,744
| +15% | +$13.3M | 0.03% | 504 |
|
|
2023
Q1 | $84.8M | Buy |
535,760
+35,430
| +7% | +$5.31M | 0.03% | 518 |
|
|
2022
Q4 | $70.2M | Sell |
500,330
-17,598
| -3% | -$2.5M | 0.03% | 634 |
|
|
2022
Q3 | $66.5M | Buy |
517,928
+13,269
| +3% | +$1.91M | 0.03% | 571 |
|
|
2022
Q2 | $71.1M | Sell |
504,659
-128
| -0% | -$18.3K | 0.03% | 565 |
|
|
2022
Q1 | $70.2M | Sell |
504,787
-90
| -0% | -$13.8K | 0.02% | 673 |
|
|
2021
Q4 | $88M | Sell |
504,877
-23,630
| -4% | -$3.94M | 0.03% | 655 |
|
|
2021
Q3 | $87.5M | Buy |
528,507
+7,338
| +1% | +$1.26M | 0.03% | 588 |
|
|
2021
Q2 | $93.8M | Buy |
521,169
+39,193
| +8% | +$7.15M | 0.03% | 542 |
|
|
2021
Q1 | $93M | Buy |
481,976
+3,271
| +0.7% | +$630K | 0.03% | 548 |
|
|
2020
Q4 | $96.7M | Buy |
478,705
+24,037
| +5% | +$4.97M | 0.03% | 499 |
|
|
2020
Q3 | $95.6M | Sell |
454,668
-962
| -0.2% | -$214K | 0.04% | 414 |
|
|
2020
Q2 | $100M | Buy |
455,630
+27,271
| +6% | +$5.45M | 0.04% | 370 |
|
|
2020
Q1 | $74.2M | Buy |
428,359
+69,852
| +19% | +$11.5M | 0.04% | 428 |
|
|
2019
Q4 | $55M | Sell |
358,507
-5,996
| -2% | -$896K | 0.02% | 726 |
|
|
2019
Q3 | $55.4M | Sell |
364,503
-10,270
| -3% | -$1.62M | 0.02% | 640 |
|
|
2019
Q2 | $57.4M | Sell |
374,773
-15,902
| -4% | -$2.43M | 0.02% | 608 |
|
|
2019
Q1 | $62.7M | Sell |
390,675
-3,489
| -0.9% | -$541K | 0.03% | 538 |
|
|
2018
Q4 | $60.8M | Buy |
394,164
+860
| +0.2% | +$134K | 0.03% | 507 |
|
|
2018
Q3 | $59.2M | Sell |
393,304
-20,364
| -5% | -$2.89M | 0.02% | 602 |
|
|
2018
Q2 | $55.9M | Sell |
413,668
-8,590
| -2% | -$1.06M | 0.02% | 603 |
|
|
2018
Q1 | $56.2M | Sell |
422,258
-33,609
| -7% | -$4.51M | 0.02% | 587 |
|
|
2017
Q4 | $67.8M | Sell |
455,867
-11,775
| -3% | -$1.6M | 0.03% | 552 |
|
|
2017
Q3 | $61.7M | Buy |
467,642
+6,701
| +1% | +$900K | 0.03% | 524 |
|
|
2017
Q2 | $61.4M | Sell |
460,941
-22,391
| -5% | -$3.02M | 0.03% | 500 |
|
|
2017
Q1 | $65.2M | Sell |
483,332
-14,719
| -3% | -$1.91M | 0.04% | 459 |
|
|
2016
Q4 | $59.8M | Sell |
498,051
-10,053
| -2% | -$1.19M | 0.03% | 471 |
|
|
2016
Q3 | $63.6M | Sell |
508,104
-40,937
| -7% | -$5.36M | 0.04% | 437 |
|
|
2016
Q2 | $76M | Buy |
549,041
+23,053
| +4% | +$2.99M | 0.05% | 373 |
|
|
2016
Q1 | $66.3M | Sell |
525,988
-134,978
| -20% | -$17.2M | 0.04% | 384 |
|
|
2015
Q4 | $83.8M | Sell |
660,966
-153,687
| -19% | -$19.1M | 0.05% | 351 |
|
|
2015
Q3 | $94.1M | Sell |
814,653
-71,708
| -8% | -$8.05M | 0.07% | 296 |
|
|
2015
Q2 | $92.2M | Sell |
886,361
-44,284
| -5% | -$4.78M | 0.06% | 326 |
|
|
2015
Q1 | $103M | Sell |
930,645
-4,265
| -0.5% | -$463K | 0.07% | 298 |
|
|
2014
Q4 | $97.4M | Buy |
+934,910
| New | +$93.5M | 0.07% | 304 |
|
Other funds holding CLX
UBS Group's CLX Position: Q2 2026 in Review
UBS Group increased its Clorox (CLX) stake by 117% in Q2 2026, buying an estimated $102M and bringing the position to 1,980,435 shares worth $189M. The position accounts for 0.02% of the portfolio, ranked #698.
UBS Group first reported a position in CLX in Q4 2014 and has held it in 47 quarters since. The position peaked at $216M in Q2 2025. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- UBS Group held 1,980,435 shares of Clorox worth $189M as of Q2 2026.
- UBS Group bought 1,066,071 Clorox shares in Q2 2026, an estimated $102M.
- Clorox made up 0.02% of UBS Group's portfolio in Q2 2026, its #698 holding.
- UBS Group first reported a position in Clorox in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Clorox position peaked at $216M in Q2 2025.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.